Matthew S. Ning

2.6k citations

89 papers · 1.4k indexed · 1 hit paper · h-index 19

Impact in

Oncology top 5%
- Lung Cancer Research Studies
Radiation top 5%
- Advanced Radiotherapy Techniques

Papers in

Radiation 22
- Advanced Radiotherapy Techniques 22
Obstetrics and Gynecology 11
- Endometrial and Cervical Cancer Treatments 11

Co-authors: Grace L. Smith Sharon H. Giordano María A. López-Olivo Pragati Advani Robert J. Volk Yimin Geng Thomas Andl Anuja Jhingran
Journals: International Journal of Radiation Oncology*Biology*Physics (18 papers)Journal of Clinical Oncology (6 papers)Brachytherapy (5 papers)Advances in Radiation Oncology (4 papers)International Journal of Gynecological Cancer (4 papers)
Partner nations: United States China Canada

In The Last Decade

Matthew S. Ning

84 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes 2019 · 254 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Journal of the National Comprehensive Cancer Network

Peers

Countries citing papers authored by Matthew S. Ning

Since Specialization

Citations

This map shows the geographic impact of Matthew S. Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Ning more than expected).

Fields of papers citing papers by Matthew S. Ning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Ning. The network helps show where Matthew S. Ning may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew S. Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew S. Ning Line = papers co-authored together Matthew S. Ning links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Recurrent Poorly Differentiated Thyroid Cancer Successfully Treated With Radiation and Immunotherapy JCEM Case Reports ·Kosuke Adachi, Matthew S. Ning, Jack Phan, Mark Zafereo, Maria Gule-Monroe, Ramona Dadu	2025	1
2	Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer Cancers ·Matthew S. Ning, Harold H. Kehrer, Joe Y. Chang, Saumil Gandhi, Zhongxing Liao, Steven H. Lin, Aileen B. Chen, James W. Welsh, Quynh‐Nhu Nguyen, Michael S. O’Reilly, Stephen G. Chun, Julianna Bronk, David C. Qian, Percy Lee	2024	2
3	Cobimetinib plus atezolizumab for RAS and NF1/2-mutated poorly differentiated thyroid carcinoma. Journal of Clinical Oncology ·Kosuke Adachi, Ramona Dadu, Naifa L. Busaidy, Renata Ferrarotto, Maria Gule-Monroe, Suyu Liu, Bryan Fellman, Michelle D. Williams, Killian Campbell, Jennifer Wang, Charles Lu, Matthew S. Ning, Brian McKinley, Scott E. Woodman, Dzifa Y. Duose, Maria E. Cabanillas, G. Brandon Gunn	2024	3
4	Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium Society Journal of Thoracic Oncology ·Henry S. Park, Andreas Rimner, Arya Amini, Joe Y. Chang, Stephen G. Chun, Jessica Donington, Martin J. Edelman, Matthew A. Gubens, Kristin Higgins, Puneeth Iyengar, Aditya Juloori, Benjamin Movsas, Zsuzsanna Németh, Matthew S. Ning, George Rodrigues, Andrea Wolf, Charles B. Simone	2024	3
5	Atezolizumab plus taxane chemotherapy for the treatment of non-BRAF, non-RAS mutated anaplastic thyroid carcinoma: Final analysis. Journal of Clinical Oncology ·Kosuke Adachi, Ramona Dadu, Renata Ferrarotto, Maria Gule-Monroe, Suyu Liu, Bryan Fellman, Michelle D. Williams, Killian Campbell, Jennifer Wang, Charles Lu, Matthew S. Ning, Brian McKinley, Scott E. Woodman, Dzifa Y. Duose, G. Brandon Gunn, Naifa L. Busaidy, Maria E. Cabanillas	2024	1
6	American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy Journal of Thoracic Oncology ·Arya Amini, Vlad G. Zaha, 王陆生, Pamela K. Woodard, Andreas Rimner, Joe Y. Chang, Stephen G. Chun, Jessica Donington, Martin J. Edelman, Matthew A. Gubens, Kristin Higgins, Puneeth Iyengar, Aditya Juloori, Benjamin Movsas, Matthew S. Ning, Henry S. Park, George Rodrigues, Andrea Wolf, Charles B. Simone	2024	4
7	Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing International Journal of Radiation OncologyBiologyPhysics ·Benjamin Li, Sylvestre Habimana, Yanjia Zhao, Bertha García, K. R. Cho, Juliette Mai, Matthew S. Ning, Anne Fourreau	2023	2
8	Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer International Journal of Particle Therapy ·Nikhil G. Thaker, David Boyce-Fappiano, Matthew S. Ning, Dario Pasalic, Alexis B. Guzman, Grace L. Smith, Emma B. Holliday, Brenda Morant-Ferrando, Adam S. Garden, Simona F. Shaitelman, G. Brandon Gunn, Clifton D. Fuller, Pierre Blanchard, Thomas W. Feeley, Robert S. Kaplan, Steven J. Frank	2021	6
9	SABR for Skull Base Malignancies: A Systematic Analysis of Set-Up and Positioning Accuracy Practical Radiation Oncology ·Shane Mesko, He Wang, Samuel Tung, Congjun Wang, Dario Pasalic, Matthew S. Ning, Todd A. Pezzi, Amy C. Moreno, Jay P. Reddy, Adam S. Garden, David I. Rosenthal, G. Brandon Gunn, Steven J. Frank, Clifton D. Fuller, William H. Morrison, Shirley Y. Su, Ehab Y. Hanna, Jack Phan	2020	5
10	Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer International Journal of Gynecological Cancer ·Travis T. Sims, Greyson Biegert, Doreen Ramogola‐Masire, 邹新智, Travis Solley, Matthew S. Ning, Molly B. El Alam, Melissa P. Mezzari, Joseph F. Petrosino, Nicola M. Zetola, Kathleen M. Schmeler, Lauren E. Colbert, Ann H. Klopp, Surbhi Grover	2020	7
11	Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy Journal of Thoracic Oncology ·Gwendolyn J. McGinnis, Matthew S. Ning, P Nitsch, Michael S. O’Reilly, Mary Frances McAleer, Albert C. Koong, Joe Y. Chang	2020	10
12	Proton Therapy in a Pandemic: An Operational Response to the COVID-19 Crisis International Journal of Particle Therapy ·Susan L. McGovern, Thomas T. Long, Salsafira Salsafira, 元春智裕, Deanna C. Martin, Matthew S. Ning, Jaciane Alves de Araújo, DM Johnsen, X Zhu, Steven J. Frank, G. Brandon Gunn	2020	2
13	Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: A systematic review and meta-analysis of 1762 patients Oral Oncology ·Ulrich Gotzig, Matthew S. Ning, Молчанова Галина Георгиевна, Vinícius F. Calsavara, Antônio Cássio Assis Pellizzon, Camilo Jose Orozco Chacón, Luiz Paulo Kowalski, Glauco Baiocchi	2019	18
14	Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up Radiotherapy and Oncology ·Matthew S. Ning, Brian J. Deegan, Jennifer Ho, Bhavana V. Chapman, Andrew J. Bishop, Pamela K. Allen, Nizar M. Tannir, Behrang Amini, Tina M. Briere, Xin A. Wang, Claudio E. Tatsui, Laurence D. Rhines, Paul D. Brown, Jing Li, Amol J. Ghia	2019	14
15	Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms International Journal of Radiation OncologyBiologyPhysics ·Jingjing Kang, Matthew S. Ning, Han Feng, Hong‐Qi Li, Houda Bahig, Eric D. Brooks, James W. Welsh, Rui Ye, Hongyu Miao, Joe Y. Chang	2019	28
16	Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study Clinical and Translational Radiation Oncology ·Ulrich Gotzig, Matthew S. Ning, Anuja Jhingran, Lilie L. Lin, S Hetts, 佐野有司, Antônio Cássio Assis Pellizzon, Camilo Jose Orozco Chacón, Glauco Baiocchi	2018	38
17	Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non–Small-Cell Lung Cancer After Definitive Radiation Therapy Clinical Lung Cancer ·Charissa Kim, Fran Cleaton-jones, Matthew S. Ning, Jay P. Reddy, Zhongxing Liao, Chad Tang, James W. Welsh, Frank E. Mott, Ya‐Chen Tina Shih, Daniel R. Gomez	2018	5
18	Outcomes and Patterns of Relapse Following Definitive Radiation Therapy for Treatment of Oligometastatic Cervical Cancer International Journal of Radiation OncologyBiologyPhysics ·Xiao Chang, Matthew S. Ning, Anuja Jhingran, Michael Frumovitz, Kathleen M. Schmeler, Patricia J. Eifel, Ann H. Klopp	2017	1
19	Evidence of high mortality in long term survivors of childhood medulloblastoma Journal of Neuro-Oncology ·Matthew S. Ning, Stephanie M. Perkins, T.A. DeWees, Eric T. Shinohara	2015	32
20	Characterization of the Merkel Cell Carcinoma miRNome Journal of Skin Cancer ·Matthew S. Ning, Annette S. Kim, Nripesh Prasad, Shawn Levy, Adams and Westlake Manufacturing Company, Thomas Andl	2014	31

About Matthew S. Ning

Matthew S. Ning is a scholar working on Radiation, Obstetrics and Gynecology, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 89 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (22 papers), Lung Cancer Diagnosis and Treatment (18 papers), Economic and Financial Impacts of Cancer (11 papers), Management of metastatic bone disease (11 papers), Endometrial and Cervical Cancer Treatments (11 papers), Lung Cancer Treatments and Mutations (9 papers), Brain Metastases and Treatment (8 papers) and Radiation Dose and Imaging (7 papers). The work is most often cited by research in Oncology (544 citations), Radiation (171 citations), Pulmonary and Respiratory Medicine (608 citations), Obstetrics and Gynecology (117 citations) and Otorhinolaryngology (51 citations). Matthew S. Ning has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Grace L. Smith, Sharon H. Giordano, María A. López-Olivo, Pragati Advani, Robert J. Volk, Yimin Geng, Thomas Andl, Anuja Jhingran, Albert Attia and Ann H. Klopp. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Brachytherapy, Advances in Radiation Oncology and International Journal of Gynecological Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact